SIOG guidelines- essential for good clinical practice in geriatric oncology

Roman Dubianski; Tanya M. Wildes; Hans Wildiers

doi:10.1016/j.jgo.2018.12.008

SIOG guidelines- essential for good clinical practice in geriatric oncology

Roman Dubianski, Tanya M. Wildes, Hans Wildiers

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	196-198
Number of pages	3
Journal	Journal of Geriatric Oncology
Volume	10
Issue number	2
DOIs	https://doi.org/10.1016/j.jgo.2018.12.008
State	Published - Mar 2019

Access to Document

10.1016/j.jgo.2018.12.008

Cite this

@article{02f4ce6263254b64bad7ce21b8eaa843,

title = "SIOG guidelines- essential for good clinical practice in geriatric oncology",

author = "Roman Dubianski and Wildes, {Tanya M.} and Hans Wildiers",

note = "Funding Information: Roman Dubianski received travel support from Roche, Amgen and Servier and fees and honoraria from Roche, Amgen, Novartis, Astra-Zeneca, and Pfizer. Funding Information: Hans Wildiers received travel support from Roche and Pfizer, and his institution received consulting fees and honoraria from Roche, Astra Zeneca, Amgen, Lilly, Novartis, Abbvie, Vifor Pharma, Pfizer, Celldex therapeutics, Janssen-CILAG, TRM Oncology, PUMA Biotechnology, ORION corporation and an unrestricted research grant from Roche. ",

year = "2019",

month = mar,

doi = "10.1016/j.jgo.2018.12.008",

language = "English",

volume = "10",

pages = "196--198",

journal = "Journal of Geriatric Oncology",

issn = "1879-4068",

number = "2",

}

TY - JOUR

T1 - SIOG guidelines- essential for good clinical practice in geriatric oncology

AU - Dubianski, Roman

AU - Wildes, Tanya M.

AU - Wildiers, Hans

N1 - Funding Information: Roman Dubianski received travel support from Roche, Amgen and Servier and fees and honoraria from Roche, Amgen, Novartis, Astra-Zeneca, and Pfizer. Funding Information: Hans Wildiers received travel support from Roche and Pfizer, and his institution received consulting fees and honoraria from Roche, Astra Zeneca, Amgen, Lilly, Novartis, Abbvie, Vifor Pharma, Pfizer, Celldex therapeutics, Janssen-CILAG, TRM Oncology, PUMA Biotechnology, ORION corporation and an unrestricted research grant from Roche.

PY - 2019/3

Y1 - 2019/3

UR - http://www.scopus.com/inward/record.url?scp=85059590953&partnerID=8YFLogxK

U2 - 10.1016/j.jgo.2018.12.008

DO - 10.1016/j.jgo.2018.12.008

M3 - Editorial

C2 - 30630747

AN - SCOPUS:85059590953

SN - 1879-4068

VL - 10

SP - 196

EP - 198

JO - Journal of Geriatric Oncology

JF - Journal of Geriatric Oncology

IS - 2

ER -

SIOG guidelines- essential for good clinical practice in geriatric oncology

Access to Document

Other files and links

Cite this